Senores Pharmaceuticals Limited (BOM:544319)
India · Delayed Price · Currency is INR 1,387.20
+64.50 (4.88%)
At close: Oct 6, 2026
Senores Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Senores Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of ₹1,614. The average 1-year stock price forecast is 16.32% higher than the current stock price, while the lowest is ₹1,500 (+8.13%) and the highest is ₹1,795 (+29.40%).
Price Target: ₹1,614 (+16.32%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Senores Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 3 | 4 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 5 |
Financial Forecast
Revenue This Year
8.97B
from 6.33B
Increased by 41.74%
Revenue Next Year
12.04B
from 8.97B
Increased by 34.29%
EPS This Year
33.70
from 26.39
Increased by 27.70%
EPS Next Year
48.88
from 33.70
Increased by 45.04%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.